Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep 20;102(38):13628-33.
doi: 10.1073/pnas.0506598102. Epub 2005 Sep 7.

Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors

Affiliations

Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors

Fumi Ohbayashi et al. Proc Natl Acad Sci U S A. .

Abstract

For gene therapy of inherited diseases, targeted integration/gene repair through homologous recombination (HR) between exogenous and chromosomal DNA would be an ideal strategy to avoid potentially serious problems of random integration such as cellular transformation and gene silencing. Efficient sequence-specific modification of chromosomes by HR would also advance both biological studies and therapeutic applications of a variety of stem cells. Toward these goals, we developed an improved strategy of adenoviral vector (AdV)-mediated HR and examined its ability to correct an insertional mutation in the hypoxanthine phosphoribosyl transferase (Hprt) locus in male mouse ES cells. The efficiency of HR was compared between four types of AdVs that contained various lengths of homologies at the Hprt locus and with various multiplicities of infections. The frequency of HR with helper-dependent AdVs (HD AdVs) with an 18.6-kb homology reached 0.2% per transduced cell at a multiplicity of infection of 10 genomes per cell. Detection of random integration at DNA levels by PCR revealed extremely high efficiency of 5% per cell. We also isolated and characterized chromosomal sites where HD AdVs integrated in a random manner. In contrast to retroviral, lentiviral, and adeno-associated viral vectors, which tend to integrate into genes, the integration sites of AdV was distributed randomly inside and outside genes. These findings suggest that HR mediated by HD AdVs is efficient and relatively safe and might be a new viable option for ex vivo gene therapy as well as a tool for chromosomal manipulation of a variety of stem cells.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Schematic representations of Hprt-targeting AdVs. Locations of Hprt genomic sequence (black box), exons (white box), inverted terminal repeats, and the packaging signal of Ad5 (arrows), adenoviral sequence (striped box),β-geo marker gene, and stuffer DNA fragment (thin line) are shown. The locations of two PCR primer pairs, used to detect HD AdHprt18.6, are shown as PCR 1 and PCR 2.
Fig. 2.
Fig. 2.
Frequencies of homologous recombination and random integration. Cells were infected with each targeting vector at an moi of 10, 100, and 1,000. Selection was initiated 4 days after infection. The values were determined by dividing the number of G418 or HAT-resistant colonies by the total number of cells plated. Frequencies of random integration and HR are shown in white bars and black bars, respectively. The numbers enclosed in parentheses indicate the percentage of HR in random integration.
Fig. 3.
Fig. 3.
Homologous recombination in smaller numbers of target cells. AB1/RV7.0PGK cells plated in a 6-well, 24-well, and 96-well at a cell density of 2 × 105 cells per cm2 in duplicate. Each cell plate was infected with HD AdHprt18.6 vector at an moi of 10. Two days after infection, the HAT selection was started. Frequency of HR was determined by dividing the total number of HAT-resistant colonies by the total number of cells plated, which were normalized by colony forming efficiency. Experiments were performed in duplicates.

Similar articles

Cited by

References

    1. Thomas, C. E., Ehrhardt, A. & Kay, M. A. (2003) Nat. Rev. Genet. 4, 346-358. - PubMed
    1. Verma, I. M. & Weitzman, M. D. (2004) Annu. Rev. Biochem. 74, 711-738. - PubMed
    1. Zwaka, T. P. & Thomson, J. A. (2003) Nat. Biotechnol. 21, 319-321. - PubMed
    1. Kmiec, E. B. (2003) J. Clin. Invest. 112, 632-636. - PMC - PubMed
    1. Seidman, M. M. & Glazer, P. M. (2003) J. Clin. Invest. 112, 487-494. - PMC - PubMed

Publication types

Substances